Abstract: Objective To observe the therapeutical effect of tetrandrine on liver fibrosis induced by bovine
serum albumin (BSA) in mice. Methods Total of 90 SD mice were divided into 6 groups: healthy control
group, model group, high dose of tetrandrine group (8 mg/kg), middle dose of tetrandrine group (4 mg/kg),
low dose of tetrandrine group (2 mg/kg), model group and colchicine group (0.1 mg/kg), 15 mice in each
group. After the mice models were made, the high, middle and low dose of tetrandrine group were given
by gavage for 80 days, abdominal aortic blood and the livers were taken after the last administration. The
serological indicators (ALT, AST, TP, ALB, LN, HA, PC-Ⅲ and Ⅳ-C) were detected and liver pathological
histology changes were observed. Results Compared with the model group, the serological indicators in
colchicine group, high and middle dose of tetrandrine group decreased significantly. After treatment, the levels
of LN, HA, PC-Ⅲ and Ⅳ-C were (45.36 ± 1.92) ng/ml, (232.54 ± 23.71) ng/ml, (30.69 ± 2.93) ng/ml, (29.20 ±
2.82) ng/ml in the high dose of tetrandrine group and (52.17 ± 2.99) ng/ml, (283.12 ± 23.19) ng/ml, (34.92 ±
2.72) ng/ml, (34.81 ± 2.92) ng/ml in the middle dose of tetrandrine group, respectively, which were obviously
superior to the model group. Compared with the model group, the degrees of cellular swelling, degeneration
and necrosis of the liver in high and middle dose of tetrandrine group and colchicine group relieved obviously.
Conclusion Tetrandrine can protect liver cells and can also prevent and treat liver fibrosis of rats.
|